Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Rules - 2020

Rules - 2020

Combat Methamphetamine Epidemic Act 2005 (CMEA)

Final Rule: Implementation of the Combat Methamphetamine Epidemic Act of 2005; Retail Sales; Notice of Transfers Following Importation or Exportation (October 29, 2020)

Drug Scheduling Actions

Final Rule: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I (November 25, 2020)

Interim Final Rule: Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment (PDF) (November 2, 2020)

Interim Final Rule: Placement of Oliceridine in Schedule II (October 30, 2020)

Interim Final Rule: Placement of Remimazolam in Schedule IV (October 6, 2020)

Final Order: Placement of Crotonyl Fentanyl in Schedule I (October 2, 2020)

Temporary Rule: Extension of Temporary Placement of N-Ethylpentylone in Schedule I of the Controlled Substances Act (August 27, 2020)

Interim Final Rule: Implementation of the Agriculture Improvement Act of 2018 (August 21, 2020)

Final Rule: Placement of Cenobamate in Schedule V (August 20, 2020)

Temporary Order: Temporary Placement of Isotonitazene in Schedule I (August 20, 2020)

Extension of Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I of the Controlled Substances Act (July 13, 2020)

Final Rule: Listing of Ethylone in Schedule I of Controlled Substances (June 8, 2020)

Final Rule: Control of the Immediate Precursor Norfentanyl Used in the Illicit Manufacture of Fentanyl as a Schedule II Controlled Substance (April 17, 2020)

Final Rule: Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals (April 15, 2020)

Temporary Placement of Fentanyl-Related Substances in Schedule I; Correction (April 10, 2020)

Interim Final Rule: Placement of Lemborexant in Schedule IV (April 7, 2020)

Final Rule: Placement of FUB-AMB in Schedule I (March 30, 2020)

Interim Final Rule: Placement of Cenobamate in Schedule V (March 10, 2020)

Interim Final Rule: Placement of Lasmiditan in Schedule V (January 31, 2020)

Temporary Rule: Extension of Temporary Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I (January 30, 2020)

Direct Final Rule: Additions to Listing of Exempt Chemical Mixtures (January 27, 2020)

Final Rule: Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I (January 24, 2020)

Final Rule: Removal of 6β-Naltrexol From Control (January 24, 2020)

Final Rule: Placement of Brexanolone in Schedule IV (January 24, 2020)

Final Rule: Placement of Solriamfetol in Schedule IV (January 7, 2020)

Electronic Prescriptions for Controlled Substances

Interim Final Rule; Reopening of Comment Period; Electronic Prescriptions for Controlled Substances (April 21, 2020)

Exempt Anabolic Steroid Products

Order with Opportunity for Comment: Exempt Anabolic Steroid Products (June 15, 2020)

Proposed Rules

Proposed Rule: Suspicious Orders of Controlled Substances (PDF) (November 2, 2020)

Proposed Rule: Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017 (PDF) (October 5, 2020)

Proposed Rule: Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a DEA Registration (September 30, 2020)

Proposed Rule: Placement of N-Ethylpentylone in Schedule I (August 27, 2020)

Proposed Rule: Reporting of Theft or Significant Loss of Controlled Substances (July 29, 2020)

Proposed Rule: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I (July 13, 2020)

Proposed Rule: Temporary Placement of Isotonitazene in Schedule I (June 18, 2020)

Proposed Rule: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I (May 15, 2020)

Proposed Rule: Placement of Zipeprol in Schedule I (May 14, 2020)

Proposed Rule: Placement of 4,4'-DMAR in Schedule I (April 7, 2020)

Proposed Rule: Controls To Enhance the Cultivation of Marihuana for Research in the United States (PDF) (March 23, 2020)

Proposed Rule: Registration and Reregistration Fees for Controlled Substance and List I Chemical Registrants (PDF) (March 16, 2020)

Proposed Rule: Registration Requirements for Narcotic Treatment Programs with Mobile Components (February 26, 2020)

Proposed Rule: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl Into Schedule I (January 30, 2020)

Registration

Final Rule: Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008; Correction (October 22, 2020)

Final Rule: Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (September 30, 2020)

Final Rule: Registration and Reregistration Fees for Controlled Substance and List I Chemical Registrants (PDF) (July 24, 2020)

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
Search for Year Round Pharmaceutical Disposal Locations.
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility